Discovery of a covalent inhibitor of KRASG12C (AMG 510) for the treatment of solid tumors.
Lanman, B.A., Allen, J.R., Allen, J.G., Amegadzie, A.K., Ashton, K.S., Booker, S.K., Chen, J.J., Chen, N., Frohn, M.J., Goodman, G., Kopecky, D.J., Liu, L., Lopez, P., Low, J.D., Ma, V., Minatti, A.E., Nguyen, T.T., Nishimura, N., Pickrell, A.J., Reed, A.B., Shin, Y., Siegmund, A., Tamayo, N.A., Tegley, C.M., Walton, M.C., Wang, H.L., Wurz, R.P., Xue, M., Yang, K.C., Achanta, P., Bartberger, M.D., Canon, J., Hollis, L.S., McCarter, J.D., Mohr, C., Rex, K., Saiki, A.Y., San Miguel, T., Volak, L., Wang, K.H., Whittington, D.A., Zech, S.G., Lipford, J.R., Cee, V.J.
J.Med.Chem.